Ovarian adenocarcinoma patient O341, who experienced a minor response by imaging and a complete response by tumor marker evaluation together with ongoing survival of 559 days, likewise presented a robust +2532% influx of CD8+ T cells into the tumor bed. Here, CD8A is linked to neoplasm.